|
64
|
211
|
5l64K |
Yeast 20s proteasome with human beta5c (1-138) and human beta6 (97-111; 118-133) in complex with epoxyketone inhibitor 18 |
|
60
|
222
|
5l60L |
Yeast 20s proteasome with human beta5c (1-138) and human beta6 (97-111; 118-133) in complex with pr-924 |
|
59
|
226
|
5l5wH |
Yeast 20s proteasome with human beta5c (1-138) and human beta6 (97-111; 118-133) |
|
70
|
244
|
5l65B |
Yeast 20s proteasome with mouse beta5i (1-138) and mouse beta6 (97-111; 118-133) in complex with carfilzomib |
|
70
|
240
|
5l62C |
Yeast 20s proteasome with human beta5c (1-138) and human beta6 (97-111; 118-133) in complex with epoxyketone inhibitor 16 |
|
58
|
204
|
5l65I |
Yeast 20s proteasome with mouse beta5i (1-138) and mouse beta6 (97-111; 118-133) in complex with carfilzomib |
|
64
|
241
|
5l65G |
Yeast 20s proteasome with mouse beta5i (1-138) and mouse beta6 (97-111; 118-133) in complex with carfilzomib |
|
67
|
233
|
5l67M |
Yeast 20s proteasome with mouse beta5i (1-138) and mouse beta6 (97-111; 118-133) in complex with pr-924 |
|
67
|
216
|
5lexM |
Native human 20s proteasome in mg-acetate at 2.2 angstrom |
|
55
|
204
|
5lezI |
Human 20s proteasome complex with oprozomib in mg-acetate at 2.2 angstrom |
|
62
|
220
|
5lezH |
Human 20s proteasome complex with oprozomib in mg-acetate at 2.2 angstrom |
|
69
|
239
|
5lexF |
Native human 20s proteasome in mg-acetate at 2.2 angstrom |
|
62
|
220
|
5lexH |
Native human 20s proteasome in mg-acetate at 2.2 angstrom |
|
74
|
248
|
5lexB |
Native human 20s proteasome in mg-acetate at 2.2 angstrom |
|
64
|
237
|
5leyC |
Human 20s proteasome complex with oprozomib at 1.9 angstrom |
|
64
|
233
|
5leyD |
Human 20s proteasome complex with oprozomib at 1.9 angstrom |
|
64
|
244
|
5leyG |
Human 20s proteasome complex with oprozomib at 1.9 angstrom |
|
63
|
233
|
5lexD |
Native human 20s proteasome in mg-acetate at 2.2 angstrom |
|
64
|
237
|
5lexC |
Native human 20s proteasome in mg-acetate at 2.2 angstrom |
|
54
|
196
|
5le5J |
Native human 20s proteasome at 1.8 angstrom |
|
69
|
230
|
5le5A |
Native human 20s proteasome at 1.8 angstrom |
|
62
|
220
|
5le5H |
Native human 20s proteasome at 1.8 angstrom |
|
65
|
244
|
5le5G |
Native human 20s proteasome at 1.8 angstrom |
|
67
|
216
|
5le5M |
Native human 20s proteasome at 1.8 angstrom |
|
66
|
201
|
5le5K |
Native human 20s proteasome at 1.8 angstrom |
|
61
|
233
|
5lezD |
Human 20s proteasome complex with oprozomib in mg-acetate at 2.2 angstrom |
|
62
|
234
|
5lezE |
Human 20s proteasome complex with oprozomib in mg-acetate at 2.2 angstrom |
|
67
|
250
|
5l6bA |
Yeast 20s proteasome with mouse beta5i (1-138) and mouse beta6 (97-111; 118-133) in complex with onx 0914 |
|
64
|
241
|
5l69G |
Yeast 20s proteasome with mouse beta5i (1-138) and mouse beta6 (97-111; 118-133) in complex with epoxyketone inhibitor 16 |
|
58
|
195
|
5l69J |
Yeast 20s proteasome with mouse beta5i (1-138) and mouse beta6 (97-111; 118-133) in complex with epoxyketone inhibitor 16 |
|
58
|
226
|
5l6cH |
Yeast 20s proteasome with mouse beta5i (1-138) and mouse beta6 (97-111; 118-133) in complex with epoxyketone inhibitor 18 |
|
71
|
244
|
5l6aB |
Yeast 20s proteasome with mouse beta5i (1-138) and mouse beta6 (97-111; 118-133) in complex with epoxyketone inhibitor 17 |
|
60
|
195
|
5l6bJ |
Yeast 20s proteasome with mouse beta5i (1-138) and mouse beta6 (97-111; 118-133) in complex with onx 0914 |
|
68
|
242
|
5l68D |
Yeast 20s proteasome with mouse beta5i (1-138) and mouse beta6 (97-111; 118-133) in complex with epoxyketone inhibitor 14 |
|
65
|
211
|
5l6aK |
Yeast 20s proteasome with mouse beta5i (1-138) and mouse beta6 (97-111; 118-133) in complex with epoxyketone inhibitor 17 |
|
70
|
243
|
5l65F |
Yeast 20s proteasome with mouse beta5i (1-138) and mouse beta6 (97-111; 118-133) in complex with carfilzomib |
|
58
|
195
|
5l63J |
Yeast 20s proteasome with human beta5c (1-138) and human beta6 (97-111; 118-133) in complex with epoxyketone inhibitor 17 |
|
61
|
241
|
5l60G |
Yeast 20s proteasome with human beta5c (1-138) and human beta6 (97-111; 118-133) in complex with pr-924 |
|
68
|
250
|
5l5wA |
Yeast 20s proteasome with human beta5c (1-138) and human beta6 (97-111; 118-133) |
|
59
|
196
|
5l66N |
Yeast 20s proteasome with mouse beta5i (1-138) and mouse beta6 (97-111; 118-133) in complex with bortezomib |
|
65
|
211
|
5l6cK |
Yeast 20s proteasome with mouse beta5i (1-138) and mouse beta6 (97-111; 118-133) in complex with epoxyketone inhibitor 18 |
|
34
|
281
|
5m32n |
Human 26s proteasome in complex with oprozomib |
|
58
|
196
|
5m2bN |
Yeast 20s proteasome with human beta5i (1-138) and human beta6 (97-111; 118-133) in complex with thiazole based inhibitor ro19 |
|
61
|
222
|
5m2bL |
Yeast 20s proteasome with human beta5i (1-138) and human beta6 (97-111; 118-133) in complex with thiazole based inhibitor ro19 |
|
79
|
375
|
5m32m |
Human 26s proteasome in complex with oprozomib |
|
0
|
13
|
5m32r |
Human 26s proteasome in complex with oprozomib |
|
63
|
241
|
5lttG |
Yeast 20s proteasome with human beta5i (1-138; r57t)in complex with pr-924 |
|
53
|
216
|
5m32M |
Human 26s proteasome in complex with oprozomib |
|
8
|
139
|
5m32p |
Human 26s proteasome in complex with oprozomib |
|
40
|
238
|
5m32S |
Human 26s proteasome in complex with oprozomib |
